Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PVLA
PVLA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PVLA News
Review Highlights Treatment Strategies for Lymphatic Malformations
1d ago
Newsfilter
Palvella Launches QTORIN™ Novel Skin Treatment Drug
4d ago
Newsfilter
Palvella COO Sells Stock Options Amid Strong Market Surge
5d ago
Fool
Palvella Executive Sells Shares Amid Positive Developments
5d ago
NASDAQ.COM
Palvella Therapeutics Director Increases Stake in Public Offering
6d ago
Fool
Palvella Launches Awareness Campaign for Microcystic Lymphatic Malformations
Mar 10 2026
Newsfilter
Palvella Closes $230 Million Upsized Public Offering
Mar 02 2026
Newsfilter
Significant Milestones in Biotech Sector This Week
Feb 27 2026
NASDAQ.COM
Palvella Therapeutics Prices $200 Million Upsized Public Offering
Feb 26 2026
NASDAQ.COM
Palvella Therapeutics Successfully Prices Upsized Public Offering
Feb 26 2026
Yahoo Finance
Wall Street Analysts Adjust Ratings
Feb 25 2026
Benzinga
US Stocks Rebound Led by Software and Chipmakers
Feb 25 2026
NASDAQ.COM
US Stocks Rebound Led by Software and Chipmakers
Feb 24 2026
NASDAQ.COM
U.S. Stocks Rise with Dow Jones Up Over 400 Points
Feb 24 2026
Benzinga
Palvella Therapeutics Shares Surge 30% After Successful Trial Results
Feb 24 2026
seekingalpha
US Stocks Rebound Slightly as Software Shares Recover
Feb 24 2026
NASDAQ.COM
Show More News
